TWM
DNA icon

TriaGen Wealth Management’s Ginkgo Bioworks DNA Stock Holding History

TriaGen Wealth Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$185K Buy
+14,381
New +$117K 0.04% 186

Other funds holding DNA

QFMHK
Q Fund Management (Hong Kong) Hong Kong $104M AUM 789.73% 1-Year Est. Return
BSWM
Boston Standard Wealth Management Winchester, Massachusetts $696M AUM 8.98% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $320M AUM 23.25% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

TriaGen Wealth Management's DNA Position: Q3 2026 in Review

TriaGen Wealth Management opened a new position in Ginkgo Bioworks (DNA) in Q3 2026: 14,381 shares worth $185K. The stake represents 0.04% of the portfolio and ranks #186 among its holdings.

10 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • TriaGen Wealth Management held 14,381 shares of Ginkgo Bioworks worth $185K as of Q3 2026.
  • Ginkgo Bioworks was a new TriaGen Wealth Management position in Q3 2026.
  • Ginkgo Bioworks made up 0.04% of TriaGen Wealth Management's portfolio in Q3 2026, its #186 holding.
  • 10 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on TriaGen Wealth Management's 13F filing for Q3 2026, filed 14 Oct 2026.